dokumendiregister.ee
Väljaminev kiriAvalik

Vastus järelepärimisele

Ravimiamet · 19. august 2025
Viit
RST-1/4289-2
Registreeritud
19. august 2025
Dokumendi liik
Väljaminev kiri
Adressaat
Sumitomo Seika
Saabumis/saatmisviis
Outlook
Funktsioon
RST Ravimistatistika tegemine
Sari
RST-1 Ravimistatistika alane kirjavahetus
Toimik
RST-1/2025
Vastutaja
Janne Sepp (RA, Peadirektori asetäitja valdkond, Ravimiohutuse osakond, Statistikabüroo)

Failid

Sisu (failidest)

Saatja: "Janne Sepp" <[email protected]> Saaja: [email protected] Teema: Vs: Data about Quetiapine and Etoricoxib Kuupäev: 2025-07-29 10:15 Dear Alberto, Thank you for your interest. DDD/1000/day for N05AH04 and M01AH05 in 2024: This data is available our website: „Estonian Statistics on Medicines 2024“ (the data for all substances) https://ravimiamet.ee/sites/default/files/documents/2025-04/DDD%202024%20ENG.pdf Statistics on Medicines (general information) https://ravimiamet.ee/en/statistics/statistics/statistics-medicines Data for previous periods is available in our statistical yearbooks: https://ravimiamet.ee/en/statistics/statistics/statistical-yearbooks Kind regards, Janne Sepp State Agency of Medicines Department of Post-Authorisation Safety Bureau of Drug Statistics Specialist Phone: +372 737 4140 [email protected] <mailto:[email protected]> Nooruse 1, 50411 Tartu, Estonia www.ravimiamet.ee This e-mail and any attachments transmitted may contain confidential and privileged information. If you are not the intended recipient, please notify the sender immediately by returning the e-mail and permanently deleting what you have recieved. Any dissemination or use of this information by a third person without permission is prohibited and may be illegaal. From: アンジェル アルベルト ヌネズ マグロ <[email protected] <mailto:[email protected]> > Sent: Tuesday, July 29, 2025 8:51 AM To: Ravimiamet <[email protected] <mailto:[email protected]> > Cc: アンジェル アルベルト ヌネズ マグロ <[email protected] <mailto:[email protected]> > Subject: RE: Data about Quetiapine and Etoricoxib Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. Dear Ravimiamet My name is Alberto Nunez and I belong to sales department of gas and chemical division in Sumitomo Seika Japan I am looking for some data about the consumption (both amount and sales) of the bellow medicines in Estonia * Quetiapine (ATC: N05AH04) * Etoricoxib (ATC: M01AH05) I wonder if there is any source of raw data of medicine consumption in Estonia. If so, would you please let me know how to access? Thank you very much for your time Alberto _____ Dr Angel Alberto Núñez Magro Phd MBA Msc BEng. Chemical and gas division Sales manager Sumitomo Seika 1-13-5 Kudan kita, Chiyoda-ku, Tokyo 102-0073 <Tel:+81-80-> Tel:+81-80-8318-1659 Linkedin: <https://www.linkedin.com/in/angelalbertonunezmagro/> https://www.linkedin.com/in/angelalbertonunezmagro/ Mail: <mailto:[email protected]> [email protected] _____
Allikas: Ravimiamet dokumendiregister →